{"result": {"id": "chatcmpl-961", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Brolucizumab** is a novel anti-vascular endothelial growth factor (VEGF) drug being tested for treating **type 3 neovascularizations** and **AMD**. It is specifically used to treat **MNV**, which stands for **medical neovascularization**.  Brolucizumab is also known as a medication used to treat **AMD**. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743182653, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 75, "prompt_tokens": 207, "total_tokens": 282, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"BROLUCIZUMAB\"\nDescription List: [\"A drug that is being tested for treating type 3 neovascularizations\", \"A drug used for treating AMD\", \"Brolucizumab is a medication used to treat MNV\", \"Brolucizumab is a novel anti-vascular endothelial growth factor (VEGF) drug\", \"Drug used to treat AMD\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_5fd9c80c45c18c23bc4b739e26b6557d1354375ebe78e4bf22ece10f8f44a1c8_v2"}